In the post-Roe environment of fear and uncertainty, femtech companies should actively review their data collection practices to ensure they are only collecting the minimum amount of data necessary for the app to function. Recent studies have shown that accurate women’s health predictions can be made by some companies that collect far less data than their competitors.

The post Here’s How Femtech And Reproductive Telehealth Companies Can Navigate Post-<em>Roe</em> Legal Challenges appeared first on Above the Law.